• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种植物提取物及其改良制剂治疗功能性消化不良。双盲安慰剂对照比较研究结果]

[A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].

作者信息

Madisch A, Melderis H, Mayr G, Sassin I, Hotz J

机构信息

Klinik für Gastroenterologie, Allgemeines Krankenhaus Celle.

出版信息

Z Gastroenterol. 2001 Jul;39(7):511-7. doi: 10.1055/s-2001-16142.

DOI:10.1055/s-2001-16142
PMID:11505331
Abstract

AIMS

To assess the efficacy and safety of the commercially available herbal preparation (Iberogast, STW-5*) containing extracts from bitter candy tuft, chamomile flower, peppermint leaves, caraway fruit, licorice root, lemon balm leaves, angelica root, celandine herbs, milk thistle fruit and its research preparation STW-5-S (without bitter candy tuft) in patients with functional dyspepsia.

PATIENTS AND METHODS

After a standardized diagnostic work-up and at least 7 days free of medication, 60 patients, diagnosed with functional dyspepsia, were recruited in a multicenter trial and randomly assigned to one of 3 treatment groups (STW-5, STW-5-S or placebo). Each patient received the treatment for 4 weeks. The main outcome variables were the improvement of a gastrointestinal symptom score (GIS), a sumscore consisted of 10 dyspeptic symptoms rated on a Likert scale. Dyspeptic symptoms were assessed at baseline, 2 and 4 weeks after treatment.

RESULTS

60 patients completed the trial (mean age 46.8 years, range 25-70, female 38 patients). Compared with placebo-group both herbal preparations STW-5 and STW-5-S showed a clinically significant improvement of GIS after 2 and 4 weeks of treatment (p < 0.001). No statistically significant difference could be observed between the efficacy of STW-5 and STW-5 S (p > 0.05), but a solid improvement of gastrointestinal symptoms could be achieved earlier with STW-5 than with its research preparation STW-5-S without bitter candy tuft (p = 0.023).

CONCLUSIONS

In patients with functional dyspepsia, the commercially available herbal preparation STW-5 and its modified dispense STW-5-S tested improved dyspeptic symptoms significantly better than placebo. The extract bitter candy tuft appeared to have an additive effect on dyspeptic symptoms.

摘要

目的

评估市售草药制剂(伊贝戈斯特,STW - 5*)(含有屈曲花、洋甘菊花、薄荷叶、香菜果、甘草根、蜜蜂花叶、当归根、白屈菜、水飞蓟果实提取物)及其研究制剂STW - 5 - S(不含屈曲花)对功能性消化不良患者的疗效和安全性。

患者与方法

经过标准化诊断检查且至少停药7天后,60例被诊断为功能性消化不良的患者参加了一项多中心试验,并随机分配至3个治疗组之一(STW - 5、STW - 5 - S或安慰剂)。每位患者接受治疗4周。主要结局变量为胃肠道症状评分(GIS)的改善情况,该评分是一个由10种消化不良症状组成的总分,采用李克特量表进行评分。在基线、治疗后2周和4周对消化不良症状进行评估。

结果

60例患者完成试验(平均年龄46.8岁,范围25 - 70岁,女性38例)。与安慰剂组相比,草药制剂STW - 5和STW - 5 - S在治疗2周和4周后GIS均有临床显著改善(p < 0.001)。STW - 5和STW - 5 - S的疗效之间未观察到统计学显著差异(p > 0.05),但与不含屈曲花的研究制剂STW - 5 - S相比,STW - 5能更早实现胃肠道症状的显著改善(p = 0.023)。

结论

在功能性消化不良患者中,市售草药制剂STW - 5及其改良剂型STW - 5 - S在改善消化不良症状方面显著优于安慰剂。屈曲花提取物似乎对消化不良症状有附加作用。

相似文献

1
[A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].[一种植物提取物及其改良制剂治疗功能性消化不良。双盲安慰剂对照比较研究结果]
Z Gastroenterol. 2001 Jul;39(7):511-7. doi: 10.1055/s-2001-16142.
2
Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial.用一种草药制剂治疗功能性消化不良。一项双盲、随机、安慰剂对照、多中心试验。
Digestion. 2004;69(1):45-52. doi: 10.1159/000076546. Epub 2004 Jan 30.
3
A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.一项随机临床试验,比较草药制剂STW 5与促动力药物西沙必利对运动障碍型功能性消化不良患者的疗效。
Z Gastroenterol. 2002 Jun;40(6):401-8. doi: 10.1055/s-2002-32130.
4
Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).荟萃分析:使用草药制剂STW 5(伊贝戈斯特)对功能性消化不良进行植物疗法
Aliment Pharmacol Ther. 2004 Dec;20(11-12):1279-87. doi: 10.1111/j.1365-2036.2004.02275.x.
5
STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study.STW 5,一种用于功能性消化不良患者的植物药:一项多中心、安慰剂对照双盲研究的结果。
Am J Gastroenterol. 2007 Jun;102(6):1268-75. doi: 10.1111/j.1572-0241.2006.01183.x.
6
Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.植物疗法治疗功能性消化不良:草药制剂STW 5的临床证据综述
Phytomedicine. 2006;13 Suppl 5:114-21. doi: 10.1016/j.phymed.2006.03.022. Epub 2006 Sep 15.
7
[Assessment of the efficacy and safety of the phytopharmacon STW 5 versus metoclopramide in functional dyspepsia--a retrolective cohort study].[植物药STW 5与甲氧氯普胺治疗功能性消化不良的疗效及安全性评估——一项回顾性队列研究]
Z Gastroenterol. 2007 Oct;45(10):1041-8. doi: 10.1055/s-2007-963357.
8
Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity.STW 5(伊贝戈斯特)及其成分对溃疡和反弹性胃酸过多的胃保护作用所涉及的机制。
Phytomedicine. 2006;13 Suppl 5:56-66. doi: 10.1016/j.phymed.2006.03.019. Epub 2006 Sep 11.
9
STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice.STW 5(伊贝格斯塔)及其单一草药成分可调节小鼠的肠道电生理。
Phytomedicine. 2006;13 Suppl 5:80-9. doi: 10.1016/j.phymed.2006.03.015. Epub 2006 May 18.
10
[The efficacy of a combination herbal medicine in the treatment of functional dyspepsia. Meta-analysis of randomized double-blind studies on the basis of a valid gastrointestinal symptom profile].[一种复方草药治疗功能性消化不良的疗效:基于有效胃肠症状谱的随机双盲研究的荟萃分析]
MMW Fortschr Med. 2004 Aug 5;146 Suppl 2:71-6.

引用本文的文献

1
Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders.草药制剂控制功能性胃肠病内脏高敏感的系统评价
Curr Pharm Biotechnol. 2024;25(13):1632-1650. doi: 10.2174/0113892010261502231102040149.
2
Non-Chinese herbal medicines for functional dyspepsia.非中药治疗功能性消化不良。
Cochrane Database Syst Rev. 2023 Jun 15;6(6):CD013323. doi: 10.1002/14651858.CD013323.pub2.
3
Herbal medicines in functional dyspepsia-Untapped opportunities not without risks.
功能性消化不良中的草药药物——未开发的机会并非没有风险。
Neurogastroenterol Motil. 2021 Feb;33(2):e14044. doi: 10.1111/nmo.14044. Epub 2020 Nov 30.
4
Efficacy and Safety of DWJ1252 Compared With Gasmotin in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study.DWJ1252与加斯莫汀治疗功能性消化不良的疗效和安全性比较:一项多中心、随机、双盲、活性对照研究。
J Neurogastroenterol Motil. 2021 Jan 30;27(1):87-96. doi: 10.5056/jnm20061.
5
Management Options for Irritable Bowel Syndrome.肠易激综合征的治疗选择。
Mayo Clin Proc. 2018 Dec;93(12):1858-1872. doi: 10.1016/j.mayocp.2018.04.032.
6
Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial.UI05MSP015CT 在功能性消化不良中的疗效和安全性:一项随机对照试验。
Gut Liver. 2018 Sep 15;12(5):516-522. doi: 10.5009/gnl17416.
7
Complementary and alternative treatment in functional dyspepsia.功能性消化不良的补充和替代疗法。
United European Gastroenterol J. 2018 Feb;6(1):5-12. doi: 10.1177/2050640617724061. Epub 2017 Aug 2.
8
Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders : A noninterventional study with Iberogast®.功能性和动力相关胃肠道疾病患者疗效的早期显现:一项关于伊比罗加®的非干预性研究。
Wien Med Wochenschr. 2018 Mar;168(3-4):89-98. doi: 10.1007/s10354-017-0578-y. Epub 2017 Jul 25.
9
STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders.STW 5(伊贝戈斯特®)——功能性胃肠疾病治疗中的一种安全有效的标准药物。
Wien Med Wochenschr. 2013 Feb;163(3-4):65-72. doi: 10.1007/s10354-012-0169-x. Epub 2012 Dec 20.
10
Phytotherapy of chronic abdominal pain following pancreatic carcinoma surgery: a single case observation.胰腺癌手术后慢性腹痛的植物疗法:单病例观察。
Int J Gen Med. 2012;5:845-8. doi: 10.2147/IJGM.S35635. Epub 2012 Oct 16.